Guangxi Engineering Center in Biomedical Materials for Tissue and Organ Regeneration & Guangxi Collaborative Innovation Center for Biomedicine, Life Sciences Institute, Guangxi Medical University, Nanning, 530021, China; Pharmaceutical college, Guangxi Medical University, Nanning, 530021, China.
Guangxi Engineering Center in Biomedical Materials for Tissue and Organ Regeneration & Guangxi Collaborative Innovation Center for Biomedicine, Life Sciences Institute, Guangxi Medical University, Nanning, 530021, China; Department of Plastic & Cosmetic Surgery, The First Affiliated Hospital of, Guangxi Medical University, Guangxi Medical University, Nanning, 530021, China.
Mater Sci Eng C Mater Biol Appl. 2020 Jul;112:110763. doi: 10.1016/j.msec.2020.110763. Epub 2020 Feb 19.
Membranes used in guided bone regeneration (GBR) are required to exhibit high mechanical strength, biocompatibility, biodegradation, osteogenic and osteoinductive potential. In our study, poly(3-hydroxybutyrate-co-4-hydroxybutyrate)(P(3HB-co-4HB))/octacalcium phosphate (OCP) (P(3HB-co-4HB)/OCP) nanofibrous membranes were fabricated by electrospinning with two different P(3HB-co-4HB) to OCP ratios (P(3HB-co-4HB):OCP = 95:5 wt% and 90:10 wt%, termed P(3HB-co-4HB)/OCP(5)and P(3HB-co-4HB)/OCP (10), respectively) for GBR. The developed P(3HB-co-4HB)/OCP nanofibrous membranes were analysed for their osteogenic and osteoinductive properties using mesenchymal stem cells (MSCs) in vitro and in a calvarial bone defect rat model. The composite P(3HB-co-4HB)/OCP nanofibrous membranes showed decreased fibre size and enhanced tensile strength compared with those of P(3HB-co-4HB) nanofibrous membranes. In the in vitro studies, the P(3HB-co-4HB)/OCP membranes facilitated cell growth and osteoblastic differentiation of MSCs and were superior to P(3HB-co-4HB) membranes. After covered on the calvarial bone defects, P(3HB-co-4HB)/OCP membranes facilitated greater neobone formation than P(3HB-co-4HB) membranes did, as the result of histological evaluation and micro-CT analysis with higher bone volume/total volume (BV/TV) ratio and bone mineral density (BMD). P(3HB-co-4HB)/OCP(10) membranes with higher OCP content showed greater stiffness and osteoinductivity than P(3HB-co-4HB)/OCP (5)membranes, demonstrating the role of OCP in the composite membranes. These results indicated that electrospun P(3HB-co-4HB)/OCP nanofibrous membranes hold promise for the clinical application of GBR.
用于引导骨再生(GBR)的膜需要具有高强度、生物相容性、可生物降解性、成骨和诱导成骨的潜力。在我们的研究中,通过静电纺丝制备了聚(3-羟基丁酸-co-4-羟基丁酸)(P(3HB-co-4HB))/八钙磷酸盐(OCP)(P(3HB-co-4HB)/OCP)纳米纤维膜,两种不同的 P(3HB-co-4HB)与 OCP 的比例(P(3HB-co-4HB):OCP = 95:5wt%和 90:10wt%,分别称为 P(3HB-co-4HB)/OCP(5)和 P(3HB-co-4HB)/OCP(10))用于 GBR。使用间充质干细胞(MSCs)体外和颅骨骨缺损大鼠模型对所开发的 P(3HB-co-4HB)/OCP 纳米纤维膜的成骨和成骨诱导特性进行了分析。与 P(3HB-co-4HB)纳米纤维膜相比,复合 P(3HB-co-4HB)/OCP 纳米纤维膜的纤维尺寸减小,拉伸强度提高。在体外研究中,P(3HB-co-4HB)/OCP 膜促进了 MSCs 的细胞生长和成骨分化,并优于 P(3HB-co-4HB)膜。在颅骨骨缺损覆盖后,P(3HB-co-4HB)/OCP 膜促进了比 P(3HB-co-4HB)膜更多的新骨形成,这是组织学评估和微 CT 分析的结果,具有更高的骨体积/总体积(BV/TV)比和骨矿物质密度(BMD)。具有更高 OCP 含量的 P(3HB-co-4HB)/OCP(10)膜比 P(3HB-co-4HB)/OCP(5)膜具有更大的刚度和成骨诱导性,这表明 OCP 在复合膜中的作用。这些结果表明,静电纺丝 P(3HB-co-4HB)/OCP 纳米纤维膜有望在 GBR 的临床应用中得到应用。